Multi-omic based molecular profiling of advanced cancer identifies treatable targets and improves survival in individual patients

A proof-of-concept study was conducted to assess whether patients with advanced stage IV cancer for whom predominantly no standard therapy was available could benefit from comprehensive molecular profiling of their tumor tissue to provide targeted therapy. Tumor samples of 83 patients were collected...

Descripción completa

Detalles Bibliográficos
Autores principales: Samsen, Alexandra, von der Heyde, Silvia, Bokemeyer, Carsten, David, Kerstin A., Flath, Bernd, Graap, Max, Grebenstein, Bianca, Heflik, Ludger, Hollburg, Wiebke, Layer, Peter, von Leitner, Eike, Overkamp, Friedrich, Saeger, Wolfgang, Schneider, Sandra, von Seydewitz, Cay-Uwe, Stang, Axel, Stein, Alexander, Zornig, Carsten, Juhl, Hartmut
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6205171/
https://www.ncbi.nlm.nih.gov/pubmed/30410678
http://dx.doi.org/10.18632/oncotarget.26198

Ejemplares similares

Ejemplares similares